During the past decade, Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases" are "Community-acquired Pneumonia (CAP)" (1 trials), "Deep Vein Thrombosis (DVT)" (1 trials), "Hospital-acquired Pneumonia (HAP)" (1 trials), "Multiple Myeloma" (1 trials) and "Pulmonary Embolism" (1 trials). Many other conditions were trialed in "Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases" in a lesser frequency.

Most popular intervention types in "Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "BL-8040 1.25mg/kg + G-CSF" (1 trials), "Edoxaban" (1 trials), "IV standard-of-care cephalosporin" (1 trials), "Placebo +G-CSF" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".